P2RY12 and coronary artery disorder: In contrast, our nationwide claims‐based study, which included a homogenous cohort of Korean patients with chronic CAD defined as 18 months after PCI using DES, found that P2Y12 inhibitor monotherapy (over 95% clopidogrel) yielded composite outcomes comparable with aspirin monotherapy.